Your browser doesn't support javascript.
loading
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
Pegourie, Brigitte; Karlin, Lionel; Benboubker, Lotfi; Orsini-Piocelle, Frédérique; Tiab, Mourad; Auger-Quittet, Sophie; Rodon, Philippe; Royer, Bruno; Leleu, Xavier; Bareau, Benoit; Cliquennois, Manuel; Fuzibet, Jean-Gabriel; Voog, Eric; Belhadj-Merzoug, Karim; Decaux, Olivier; Rey, Philippe; Slama, Bohrane; Leyronnas, Cecile; Zarnitsky, Charles; Boyle, Eileen; Bosson, Jean Luc; Pernod, Gilles.
Afiliação
  • Pegourie B; Department of Hematology, University Hospital Grenoble-Alpes, Grenoble, Auvergne-Rhône-Alpes, France.
  • Karlin L; Department of Hematology, University Hospital Lyon, Lyon, Auvergne-Rhône-Alpes, France.
  • Benboubker L; Department of Hematology, University Hospital Tours, Tours, Centre-Val de Loire, France.
  • Orsini-Piocelle F; Department of Clinical Hematology, Hospital Annecy-Genevois, Annecy, Haute-Savoie, France.
  • Tiab M; Department of Clinical Hematology, Hospital de Vendée, La Roche sur Yon, Pays de la Loire, France.
  • Auger-Quittet S; Department of Onco-Hematology, Clinique Beau Soleil, Montpellier, Occitanie, France.
  • Rodon P; Department of Hematology, Hospital Perigueux, Perigueux, Dordogne, France.
  • Royer B; Department of Hematology, University Hospital Saint Louis, Paris, Île-de-France, France.
  • Leleu X; Department of Hematology, University Hospital Poitiers, Poitiers, Nouvelle-Aquitaine, France.
  • Bareau B; Department of Hematology, Hôpital Privé Sévigné - Pôle Santé Ouest Vivalto, Cesson Sévigné, Brittany, France.
  • Cliquennois M; Department of Hematology, Hospital St Vincent de Paul, Lille, Hauts-de-France, France.
  • Fuzibet JG; Department of Hematology, University Hospital Nice, Nice, Provence-Alpes-Côte d'Azur, France.
  • Voog E; Department of Oncology, Centre Jean Bernard, Le Mans, Pays de la Loire, France.
  • Belhadj-Merzoug K; Department of Hematology, University Hospital Henri Mondor, Créteil, Île-de-France, France.
  • Decaux O; Department of Hematology, University Hospital, Rennes, Brittany, France.
  • Rey P; Department of Hematology, Centre Léon Bérard, Lyon, Auvergne-Rhône-Alpes, France.
  • Slama B; Department of Clinical Hematology, CH Avignon, Avignon, Provence-Alpes-Côte d'Azur, France.
  • Leyronnas C; Department of Clinical Hematology, Institut Daniel Hollard, Grenoble, Auvergne-Rhône-Alpes, France.
  • Zarnitsky C; Department of Clinical Hematology, Hospital Le Havre, Le Havre, Normandy, France.
  • Boyle E; Department of Clinical Hematology, University Hospital Lille, Lille, Hauts-de-France, France.
  • Bosson JL; Department of Biostatistics, University Hospital Grenoble-Alpes, Grenoble, Auvergne-Rhône-Alpes, France.
  • Pernod G; Department of Vascular Medicine, CNRS / TIMC-IMAG UMR 5525/Themas and F-CRIN InnoVTE Network, Grenoble, Auvergne-Rhône-Alpes, France.
Am J Hematol ; 94(6): 635-640, 2019 06.
Article em En | MEDLINE | ID: mdl-30859608
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Protocolos de Quimioterapia Combinada Antineoplásica / Tromboembolia Venosa / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Protocolos de Quimioterapia Combinada Antineoplásica / Tromboembolia Venosa / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França